Literature DB >> 16235172

Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.

Imtiaz Yakub1, Kristy M Lillibridge, Ana Moran, Omar Y Gonzalez, John Belmont, Richard A Gibbs, David J Tweardy.   

Abstract

BACKGROUND: Infection with the flavivirus West Nile virus (WNV) is a growing problem across the United States, where there is a case-fatality rate of 15%-29% in individuals >70 years old and no consistently effective treatment. Susceptibility to WNV disease in inbred strains of mice was mapped to a nonsense mutation in the gene encoding the 1b isoform of 2'-5'-oligoadenylate synthetase (OAS), a member of the OAS/RNase L system of innate viral resistance. Genetic susceptibility to severe WNV disease in humans has not been determined.
METHODS: We sequenced each exon within all OAS and RNASEL genes in 33 individuals hospitalized with WNV infection in Houston to assess if there is a defect in this system in patients with severe WNV disease.
RESULTS: Sequencing did not reveal any insertions, deletions, or nonsense mutations in any OAS or RNASEL gene. However, comparison of the exonic sequences between case patients and control subjects identified 23 single nucleotide polymorphisms (SNPs), including a synonymous SNP in OASL exon 2 (rs3213545), in which the reference allele occurred at a higher frequency in case patients (P < .004).
CONCLUSION: Because the reference allele contains a splice enhancer site, our finding suggests that the RNA transcripts generated from this allele may undergo increased splicing, which results in a dominant-negative OASL isozyme similar to the nonsense/truncation mutant form of Oas1b in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16235172     DOI: 10.1086/497340

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

Authors:  Folkert Steinhagen; Corinna Meyer; Debra Tross; Mayda Gursel; Takahiro Maeda; Sven Klaschik; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2012-07-02       Impact factor: 4.962

Review 2.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Authors:  Xiaowen Su; Leland J Yee; KyungAh Im; Shannon L Rhodes; YongMing Tang; Xiaomei Tong; Charles Howell; Darmendra Ramcharran; Hugo R Rosen; Milton W Taylor; T Jake Liang; Huiying Yang
Journal:  J Hepatol       Date:  2008-05-20       Impact factor: 25.083

Review 4.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

Review 5.  The top five "game changers" in vaccinology: toward rational and directed vaccine development.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  OMICS       Date:  2011-08-04

Review 6.  Risk factors for West Nile virus infection and disease in populations and individuals.

Authors:  Ruth R Montgomery; Kristy O Murray
Journal:  Expert Rev Anti Infect Ther       Date:  2015-01-30       Impact factor: 5.091

Review 7.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor.

Authors:  Jianzhong Zhu; Yugen Zhang; Arundhati Ghosh; Rolando A Cuevas; Adriana Forero; Jayeeta Dhar; Mikkel Søes Ibsen; Jonathan Leo Schmid-Burgk; Tobias Schmidt; Madhavi K Ganapathiraju; Takashi Fujita; Rune Hartmann; Sailen Barik; Veit Hornung; Carolyn B Coyne; Saumendra N Sarkar
Journal:  Immunity       Date:  2014-06-12       Impact factor: 31.745

9.  OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.

Authors:  Jonathan J Rios; Joann G W Fleming; Uneeda K Bryant; Craig N Carter; John C Huber; Maureen T Long; Thomas E Spencer; David L Adelson
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

10.  2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.

Authors:  Iana H Haralambieva; Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Hum Immunol       Date:  2010-01-31       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.